- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MiniMed Group Inc (MMED)
MiniMed Group Inc stock price live, this page displays NASDAQ MMED stock exchange data. View the MMED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MiniMed Group Inc real time stock price chart below.
What Is the MiniMed Group Inc Stock Price Today?
The MiniMed Group Inc stock price today is 22.44.
What Is the Stock Symbol for MiniMed Group Inc?
The stock symbol for MiniMed Group Inc is "MMED."
What Stock Exchange Does MiniMed Group Inc Trade On?
MiniMed Group Inc is listed and trades on the NASDAQ stock exchange.
Is MiniMed Group Inc a Good Stock to Buy?
Determining whether MiniMed Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MMED quote. (ISIN: US60365F1093)
What Is the MiniMed Group Inc Stock Price Today?
The MiniMed Group Inc stock price today is 22.44.
What Is the Stock Symbol for MiniMed Group Inc?
The stock symbol for MiniMed Group Inc is "MMED."
What Stock Exchange Does MiniMed Group Inc Trade On?
MiniMed Group Inc is listed and trades on the NASDAQ stock exchange.
Is MiniMed Group Inc a Good Stock to Buy?
Determining whether MiniMed Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MMED quote. (ISIN: US60365F1093)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.10
23.17
52 wk Range
10.65
24.43
MMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.1023.17
52 wk Range
10.6524.43
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MMED Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
24.83
Upside
+10.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
MiniMed Group Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
MiniMed Group stock surges on analyst upgrades- Investing.com
- MiniMed Group Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - MiniMed Group stock surges on analyst upgrades
- Investing.com
MiniMed Group Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
11 Buy
1 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24.83
(+10.67% Upside)
MiniMed Group Inc Earnings Call Summary for Q1/2027
- MiniMed Q1 FY2027 revenue rose 15.8% organically to $843M, beating internal expectations; stock jumped 5.06% to $21.29, near 52-week high.
- Company raised FY2027 organic revenue growth guidance to ~10.5% from ~10%; maintained adjusted EBITDA margin target at ~16% for full year.
- U.S. revenue grew 13.1% organically while international sales climbed 16.9%; new pump sales rose 7.7% to 34,000 units with U.S. up over 20%.
- Adjusted EBITDA reached $83M with 9.9% margin (12.2% excluding temporary items); negative $90M free cash flow due to separation costs.
- Key product milestones: MiniMed Flex Europe launch Nov 2027, Fit U.S. launch summer 2027, Vivera closed-loop algorithm H2 2027 pending FDA approval.
Last Updated: 09/01/2026, 09:48 PM
Read Full TranscriptEarnings
Latest Release
Jun 03, 2026
EPS / Forecast
-0.68 / 0.16
Revenue / Forecast
837M / 770.87M
Compare MMED to Peers and Sector
Metrics to compare | MMED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.1x | −163.7x | −0.3x | |
PEG Ratio | 0.51 | −2.19 | 0.00 | |
Price/Book | 1.7x | 23.5x | 2.6x | |
Price / LTM Sales | 2.0x | 8.5x | 3.0x | |
Upside (Analyst Target) | 15.9% | 29.8% | 53.8% | |
Fair Value Upside | Unlock | −14.1% | 8.6% | Unlock |
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the MiniMed (MMED) Stock Price Today?
The MiniMed stock price today is 22.44 USD.
What Stock Exchange Does MiniMed Trade On?
MiniMed is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for MiniMed?
The stock symbol for MiniMed is "MMED."
What Is the MiniMed Market Cap?
As of today, MiniMed market cap is 6.31B USD.
What Is MiniMed's Earnings Per Share (TTM)?
The MiniMed EPS (TTM) is -1.19.
When Is the Next MiniMed Earnings Date?
MiniMed will release its next earnings report on Oct 22, 2026.
From a Technical Analysis Perspective, Is MMED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has MiniMed Stock Split?
MiniMed has split 0 times.
What is the current trading status of MiniMed (MMED)?
As of Sep 11, 2026, MiniMed (MMED) is trading at a price of 22.44 USD, with a previous close of 22.44 USD. The stock has fluctuated within a day range of 22.10 USD to 23.17 USD, while its 52-week range spans from 10.65 USD to 24.43 USD.
What Is MiniMed (MMED) Price Target According to Analysts?
The average 12-month price target for MiniMed is 24.83 USD, with a high estimate of 28 USD and a low estimate of 15 USD. 11 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an +10.67% Upside potential.
What Is the MMED Premarket Price?
MMED's last pre-market stock price is 23.55 USD. The pre-market share volume is 290.00, and the stock has decreased by 1.11, or 4.95%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.